Oxidative damage and inflammation in obese diabetic emirati subjects

Nutrients

Volumn 6, Issue 11, 2014, Pages 4872-4880

  Gariballa, Salah ^a   Kosanovic, Melita ^a   Yasin, Javed ^a   Essa, Awad El ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Inflammation; Obesity; Oxidative damage; Visceral fat

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; MALONALDEHYDE; ORAL ANTIDIABETIC AGENT; RETINOL; STATIN (PROTEIN); TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ASSAY; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC OBESITY; EMIRATI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIP CIRCUMFERENCE; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; KIDNEY FUNCTION TEST; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); WAIST CIRCUMFERENCE; BLOOD; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY; UNITED ARAB EMIRATES;

ADIPOSITY; ASCORBIC ACID; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA; UNITED ARAB EMIRATES; VITAMIN A; VITAMIN E; WAIST CIRCUMFERENCE;

EID: 84908689467     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6114872     Document Type: Article

References (21)

1. World Health Orgnization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Org. Tech. Rep. Ser. 2000, 894, 1–253.
2. McLellan, F. Obesity rising to alarming levels around the world. Lancet 2002, 359, 1412, doi:10.1016/S0140-6736(02)08397-6.
3. British Nutrition Foundation. The report of a British nutrition foundation task force. In Cardiovascular Disease, Diet, Nutrition and Emerging Risk Factors; Balckwell Publishing Ltd.: Oxford, UK, 2005.
4. Malik, A.; Babir, A.; Abi Saab, B.; Roglic, G.; King, H. Glucose intolerance and associated factors in the UAE. Diabetes Res. Clin. Pract. 2005, 69, 188–195.
5. Baik, I.; Ascherio, A.; Rimm, E.B.; Giovannucci, E.; Spiegelman, D.; Stampfer, M.J.; Willett, W.C. Adiposity and mortality in men. Am. J. Epidemiol. 2000, 152, 264–271.
6. Rexode, K.M.; Carey, V.J.; Hennekens, C.H.; Walters, E.E.; Colditz, G.A.; Stampfer, M.J.; Willett, W.C.; Manson, J.E. Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280, 1843–1848.
7. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363, 157–163.
8. Yusuf, S.; Hawken, S.; Ounpuu, S.; Baustista, L.; Franzosi, M.G.; Commerford, P.; Lang, C.C.; Rumboldt, Z.; Onen, C.L.; Lisheng, L. et al. Obesity and risk of myocardial infarction in 27,000 participants from 52 countrries: A case-control study. Lancet 2006, 366, 1640–1649.
9. Yusuf, S.; Hawken, S.; Ounpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigos, J. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004, 364, 937–952.
10. Trayhurn, P. The bology of obesity. Proc. Nutr. Soc. 2005, 64, 31–38.
11. Pouliot, M.C.; Despres, J.P.; Lemieux, S.; Moorjani, S.; Bouchard, C.; Tremblay, A.; Nadeau, A.; Lupien, P.J. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am. J. Cardiol. 1994, 73, 460–468.
12. Gariballa, S.; Afandi, B.; Abuhaltem, M.; Yassin, J.; Habib, H.; Ibrahim, W. Oxidative damage and inflammation in obese diabetic Emirati subjects supplemented with antioxidants and B-vitamins. Nutr. Metab. (Lond.) 2013, 10, 21, doi:10.1186/1743-7075-10-21.
13. Li, X.Y.; Chow, C.K. An improved method for the measurement of malondialdehyde in biological samples. Lipids 2004, 29, 73–75.
14. Levine, R.L.; Garland, D.; Oliver, C.N.; Amici, A.; Climent, I.; Lenz, A.; Ahn, B.; Shaltiel, S.; Stadtman, E. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464–478.
15. Esteghamati, A.; Ashraf, H.; Rashidi, A.; Meysamie, A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res. Clin. Pract. 2008, 82, 104–107.
16. Hill, M.F. Emerging role for antioxidant therapy in protection against diabetic cardiac complications: Experimental and clinical evidence for utilization of classic and new antioxidants. Curr. Cardiol. Rev. 2008, 4, 259–268.
17. Evans, J.L. Antoxidants: Do they have a role in the treatment of insulin resistance? Indian J. Med. Res. 2007, 125, 355–372.
18. Evans, J.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Oxidative stress and stress activated signalling pathways: A unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23, 599–622.
19. Carter, P.; Gray, L.J.; Troughton, J.; Khunti, K.; Davies, M.J. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: Systematic review and meta-analysis. BMJ 2010, 341, c4229, doi:10.1136/bmj.c4229.
20. Puchau, B.; Zulet, A.; Gonzalez, A.; Hermsdorff, H.; Martinez, J. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young men. Nutrition 2010, 26, 534–541.
21. Barter, P. High density lipoprotein: A therapeutic target in type 2 diabetes. Endocrinol. Metab. 2013, 28, 169–177.